Healthcare provider profile · identity verified

Samuel Terry Johnson, M.D.

Family Practice · BOLIVAR, TN · NPI 1427296276

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	670	256
Amlodipine Besylate	Amlodipine Besylate	450	176
Albuterol Sulfate Hfa	Albuterol Sulfate	233	67
Tamsulosin Hcl	Tamsulosin Hcl	223	71
Losartan Potassium	Losartan Potassium	205	85
Lisinopril	Lisinopril	161	56
Hydrochlorothiazide	Hydrochlorothiazide	124	46
Metformin Hcl	Metformin Hcl	122	50
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	121	33
Metoprolol Succinate	Metoprolol Succinate	120	47
Famotidine	Famotidine	115	41
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	107	51
Furosemide	Furosemide	104	41
Gabapentin	Gabapentin	104	46
Pantoprazole Sodium	Pantoprazole Sodium	103	42
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	99	34
Omeprazole	Omeprazole	92	32
Allopurinol	Allopurinol	86	34
Farxiga	Dapagliflozin Propanediol	86	26
Montelukast Sodium	Montelukast Sodium	84	27
Glipizide	Glipizide	83	28
Metoprolol Tartrate	Metoprolol Tartrate	83	31
Hydralazine Hcl	Hydralazine Hcl	81	33
Carvedilol	Carvedilol	79	33
Mounjaro	Tirzepatide	70	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	23
Levothyroxine Sodium	Levothyroxine Sodium	66	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	62	15
Rosuvastatin Calcium	Rosuvastatin Calcium	58	23
Spironolactone	Spironolactone	57	21
Diclofenac Sodium	Diclofenac Sodium	55	28
Clopidogrel	Clopidogrel Bisulfate	52	21
Chlorthalidone	Chlorthalidone	44	19
Ozempic	Semaglutide	43	suppressed
Trazodone Hcl	Trazodone Hcl	43	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	15
Tizanidine Hcl	Tizanidine Hcl	39	26
Glimepiride	Glimepiride	36	15
Potassium Chloride	Potassium Chloride	36	19
Duloxetine Hcl	Duloxetine Hcl	31	12
Eliquis	Apixaban	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	12
Atenolol	Atenolol	27	11
Azelastine Hcl	Azelastine Hcl	26	15
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Dexamethasone	Dexamethasone	25	23
Meloxicam	Meloxicam	25	13
Clonidine Hcl	Clonidine Hcl	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Sertraline Hcl	Sertraline Hcl	24	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	23	suppressed
Glyburide	Glyburide	21	suppressed
Januvia	Sitagliptin Phosphate	21	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	20	suppressed
Entresto	Sacubitril/Valsartan	20	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	12
Levetiracetam	Levetiracetam	20	suppressed
Pregabalin	Pregabalin	20	12
Simvastatin	Simvastatin	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Ibuprofen	Ibuprofen	15	11
Bupropion Xl	Bupropion Hcl	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Indapamide	Indapamide	13	suppressed
Linzess	Linaclotide	13	suppressed
Prednisone	Prednisone	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	11
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	12
Fluconazole	Fluconazole	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Synjardy Xr	Empagliflozin/Metformin Hcl	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	11	suppressed
Aripiprazole	Aripiprazole	11	suppressed
Baclofen	Baclofen	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Glipizide Er	Glipizide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error